Literature DB >> 393291

Treatment of hypertension with a beta-adrenoceptor blocker. A multicentre trial with pindolol.

J Rosenthal, H Kaiser, A Raschig, D Welzel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 393291

Source DB:  PubMed          Journal:  Br J Clin Pract        ISSN: 0007-0947


× No keyword cloud information.
  6 in total

1.  Stereoselective renal clearance of pindolol in humans.

Authors:  P H Hsyu; K M Giacomini
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

Review 2.  Pindolol--the pharmacology of a partial agonist.

Authors:  B J Clark; K Menninger; A Bertholet
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 3.  Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Effect on heart rate over 24 hours of pindolol administered for 14 days.

Authors:  J P Kantelip; J F Trolese; P G Cromarias; P Duchêne-Marullaz
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 5.  Is the ISA of pindolol beta 2-adrenoceptor selective?

Authors:  W H Aellig; B J Clark
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

6.  An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.

Authors:  P M McCaffrey; J G Riddell; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.